Clinical Trial: A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: An Open-Label Clinical Study to Evaluate the Effects of Multiple Oral Doses of Rifabutin on the Single-Dose Pharmacokinetics of MK-4646 in Healthy Participants
Brief Summary:
Researchers have designed a new study medicine called MK-4646 as a new way to treat human immunodeficiency virus (HIV).Rifabutin is a medication used to treat tuberculosis (TB).Researchers want to learn about MK-4646 when taken at the same time as Rifabutin.They want to:Measure a person's blood to find out if the amount of MK-4646 in the blood is the same when MK-4646 is taken alone or with Rifabutin Learn about the safety of MK-4646 when taken alone or with Rifabutin and if people tolerate it
Read more